Affiliations
PMID: # DOI: 10.1016/j.cell.2024.10.017
Abstract
Recent reports raise concerns on the changing epidemiology of mpox in the Democratic Republic of the Congo (DRC). High-quality genomes were generated for 337 patients from 14/26 provinces to document whether the increase in number of cases is due to zoonotic spillover events or viral evolution, with enrichment of APOBEC3 mutations linked to human adaptation. Our study highlights two patterns of transmission contributing to the source of human cases. All new sequences from the eastern South Kivu province (n = 17; 4.8%) corresponded to the recently described clade Ib, associated with sexual contact and sustained human-to-human transmission. By contrast, all other genomes are clade Ia, which exhibits high genetic diversity with low numbers of APOBEC3 mutations compared with clade Ib, suggesting multiple zoonotic introductions. The presence of multiple clade I variants in urban areas highlights the need for coordinated international response efforts and more studies on the transmission and the reservoir of mpox.
近期报告引发了对刚果民主共和国(DRC)mpox(猴痘)流行病学变化的担忧。我们为来自14个省的337名患者生成了高质量的基因组,以记录病例增加是由于动物溢出事件还是病毒进化,并发现与人类适应相关的APOBEC3突变的富集。我们的研究突出了两种传播模式,帮助解释人类病例的来源。来自东南基伍省的所有新序列(n = 17;占4.8%)对应于最近描述的Ib进化分支,与性接触和持续的人际传播相关。相反,其他所有基因组属于Ia进化分支,展现出高遗传多样性,但与Ib进化分支相比APOBEC3突变数量较少,这表明存在多次动物溢出引入。在城市地区发现多种Ia进化分支变异突显了需要协调国际应对措施以及对mpox传播和宿主的更多研究。
关键词:猴痘,猴痘病毒,mpox,Monkeypox,Clade Ia, Clade Ib, Clade 1a, Clade 1b,佰乐博,佰乐博生物
相关产品
货号 | 品名 | 简介 | Target |
---|---|---|---|
EVV17101 | Recombinant Monkeypox virus/MPXV A5L Protein | ||
EVV12701 | Recombinant Monkeypox virus/MPXV H3L Protein | ||
KAV12701 | Human Anti-Monkeypox Virus (MPXV) IgG ELISA Kit (H3L) | PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Monkeypox virus H3L antigen has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Human Anti-Monkeypox virus IgG (H3L) in the sample competitively binds to the pre-coated protein with biotin-labeled Human Anti-Monkeypox virus IgG (H3L). After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Human Anti-Monkeypox virus IgG (H3L) bound in the initial step. The color development is stopped and the intensity of the color is measured. | H3L |
KAV13101 | Human Anti-Monkeypox Virus (MPXV) IgG ELISA Kit (A35R) | PRINCIPLE OF THE ASSAY. This assay employs the quantitative competitive enzyme immunoassay technique. A recombinant Monkeypox virus A35R antigen has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Human Anti-Monkeypox Virus IgG (A35R) in the sample competitively binds to the pre-coated protein with biotin-labeled Human Anti-Monkeypox Virus IgG (A35R). After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Human Anti-Monkeypox Virus IgG (A35R) bound in the initial step. The color development is stopped and the intensity of the color is measured. | A35R |